Endo International is the latest drugmaker to file for chapter 11 bankruptcy protection in connection with opioid litigation in the US, after agreeing a $6 billion deal with creditors that
Endo Pharmaceuticals and Endo Health Solutions, makers of Percocet, Opana, and Percodan, have settled with the State of Florida for $65 million (£47.7 million) to end their legal battle ove
The US regulator must make a decision on Endo Pharmaceuticals’ opioid painkiller, after its independent advisers said that the risks of abuse now outweigh its benefits.
Novartis has posted a healthy rise in sales and profits in the first full quarter since it separated from Sandoz and proposed former Bristol Myers Squibb’s chief executive
It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.